Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.97 USD | -1.97% | -6.38% | +1.12% |
Mar. 15 | Recursion Pharmaceuticals Insider Sold Shares Worth $537,190, According to a Recent SEC Filing | MT |
Mar. 11 | Recursion Pharmaceuticals to Open London Office | MT |
Business Summary
Number of employees: 500
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug Discovery
100.0
%
| 40 | 100.0 % | 45 | 100.0 % | +11.88% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 40 | 100.0 % | 45 | 100.0 % | +11.88% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 41 | 13-11-04 | |
Blake Borgeson
FOU | Founder | 42 | 13-11-04 |
Dean Li
FOU | Founder | 62 | 13-11-04 |
Tina Larson
PSD | President | 49 | 18-06-30 |
Michael Secora
DFI | Director of Finance/CFO | 41 | 20-02-29 |
Chief Tech/Sci/R&D Officer | - | - | |
Chief Tech/Sci/R&D Officer | - | 21-08-15 | |
Benjamin Mabey
CTO | Chief Tech/Sci/R&D Officer | 41 | 17-02-28 |
Laura Schaevitz
CTO | Chief Tech/Sci/R&D Officer | - | - |
David Mauro
CTO | Chief Tech/Sci/R&D Officer | 59 | 23-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Hershberg
BRD | Director/Board Member | 61 | 20-03-19 |
Chairman | 60 | 20-03-31 | |
Dean Li
FOU | Founder | 62 | 13-11-04 |
Blake Borgeson
FOU | Founder | 42 | 13-11-04 |
Zachary Bogue
BRD | Director/Board Member | 48 | 18-07-31 |
Zavain Dar
BRD | Director/Board Member | 35 | 16-08-31 |
Founder | 41 | 13-11-04 | |
Director/Board Member | 47 | 20-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 10 | 7,509,871 | 0 | 0 | 83.39 % |
Stock B | 1 | 227,143,401 | 195,683,133 ( 86.15 %) | 0 |
Company contact information
Recursion Pharmaceuticals, Inc.
41 South Rio Grande Street
84101, Salt Lake City
+
http://www.recursion.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.12% | 2.34B | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |
- Stock
- Equities
- Stock Recursion Pharmaceuticals, Inc. - Nasdaq
- Company Recursion Pharmaceuticals, Inc.